Clinical Trial

Vascular Access and Intraosseus

Study acronym: IO_nursing
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2026 (before its estimated July 3, 2026 completion). Its status may not reflect the trial's current state.
Summary
Rapid administration of epinephrine is an essential component of advanced life support during cardiac arrest. Peripheral intravenous (IV) access is commonly used for drug delivery, while intraosseous (IO) access is an alternative when IV access is not readily available. In addition, epinephrine may be administered using different drug presentations, such as ampoules or prefilled syringes, which may influence procedural workflow during resuscitation.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-04-03 -> 2026-07-03 2026-04-30
Trial Details
NCT Number NCT07471555
Lead Sponsor University of Valencia
Conditions To Compare the Time Required to Administer 1 mg of Epinephrine, as Well as the Total Procedure
Enrollment 52 participants
Start Date 2026-04-02
Primary Completion 2026-07-03 (estimated)
Study Completion 2026-12-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-29